RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy? - Wikidata - awgldk - TriplyDB

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

http://www.wikidata.org/entity/Q40396297

about

Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis.Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.Extracellular matrix in bone marrow can mediate drug resistance in myeloma.Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitis.RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.The role of hyaluronic acid in hemopoietic stem cell biology.Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.New aspects of gene-silencing for the treatment of cardiovascular diseases Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.Peptide vaccines for patients with acute myeloid leukemia.Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.Androgen receptor regulates CD168 expression and signaling in prostate cancer.The hyaluronan receptor RHAMM regulates extracellular-regulated kinase.Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma.Hyaluronan stimulates mobilization of mature hematopoietic cells but not hematopoietic progenitors Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease

P2860

Q26786070-74986C8F-8FCB-4C03-A5B8-A108AB4B2A8D Q27021261-8ED34FB8-5B8A-4D27-A0ED-77CB3CA4DA35 Q30523754-6251128B-8E95-407D-B4D6-A60CD12C65AE Q33536294-51C26B0D-8E09-4860-9D63-5DDDBB18D282 Q35370946-99F0ADC5-6CD0-4E75-A9C0-E83B091DC75E Q35637833-C3517986-6176-4C4F-B2E9-32403225EFF5 Q35856862-26C090DB-F170-4A5A-BCFD-6D1B695C14B8 Q36072049-DE49AF60-184C-4EC4-97A5-2436BC96499C Q36194659-59370589-1131-4A24-B99F-E1E7E3697F43 Q36286091-D9572537-9761-4B1C-8847-98797E16E124 Q36366953-76584DE9-CD84-4363-B7A0-916776B5AFF5 Q36804635-EE01414A-52A2-40E1-A733-E07496AA3E8A Q37188974-A9C0DA44-19F2-444B-B792-371BBFDF2084 Q37277425-0C101A1D-8510-4CFC-B9E4-CEF5490E5033 Q37457741-4B21BF99-7527-41C7-8137-B31FD6EFBD7A Q37608316-BDD6E95E-2F9E-481A-989F-D5942D9239BA Q38199975-4C0EF002-4415-42F2-A20B-AE706EEF2F99 Q38949468-A58F38E5-CFEF-4BEC-83EF-D203B736621E Q40028472-BFC0A631-B0D4-415A-9B9B-98FA8695EA05 Q41036869-9B92EC23-1514-4C07-BB24-220A407E96BE Q41178761-08A2835D-437B-484D-BD0C-6A75C35980D0 Q41372245-8403539F-05F7-4AC8-AD96-39D6D7BED9E4 Q42502219-21746F8E-8745-4B5D-AD19-FF0925F33E6C Q43837471-4DC04D7C-C4E6-4B9A-BCAB-7851D34F3CE3 Q58124882-F1D917CF-83D4-4E4F-AA2F-82242FBA4BC2

P2860

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

http://www.wikidata.org/entity/Q40396297

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

RHAMM, a receptor for hyaluron ...... mediator in B cell malignancy?

@en

type

label

RHAMM, a receptor for hyaluron ...... mediator in B cell malignancy?

@en

prefLabel

RHAMM, a receptor for hyaluron ...... mediator in B cell malignancy?

@en

P1433

Q40396297-5F2A9EF7-D8DE-4E22-AB14-233E1F8035C8

P1476

Q40396297-7589392B-982E-47C1-B549-C3E82DD4D906

P2093

Q40396297-01685A03-307E-4BC8-802D-6DA6A5E1F1C7

Q40396297-32F7FD01-8CEE-4E0D-9C01-1D0A65D6B6F8

Q40396297-5DD7101A-A2B1-46C6-BB0D-A00790E6318E

Q40396297-6977778C-D0EB-492C-8DD9-81E13D99CC61

Q40396297-AD3E419D-8663-4A89-9A16-FA25A9EFE691

Q40396297-AF05CB5C-A72B-43CB-89AF-B8B9CAF9A543

P2860

Q40396297-12D96BC5-65F6-48A4-B0AA-BFC2E9C735FD

Q40396297-259B28FA-D1B2-4D27-87B8-EF2400E791C6

Q40396297-2746350B-E3A9-43A3-9D21-3EFC7BAC046E

Q40396297-4B267A19-271E-4C82-9A02-084E39B96593

Q40396297-51784FDC-15D9-4ABF-9C86-51ABF945EDF1

Q40396297-533C9E21-EDEE-4FF5-89E5-CC1D5376BAC3

Q40396297-5897C06A-7A96-4D2D-A739-7BD905935965

Q40396297-58AFC6A4-B237-4FD1-8C6F-6AC9AD980143

Q40396297-595A575A-1268-4F31-998F-492B8D51846F

Q40396297-5C908713-FEB0-4B3D-8D9A-CC77DFF67ADB

P304

Q40396297-4094CBF5-B156-4BF4-BD6E-D33574313E5D

P31

Q40396297-6C90D273-6C5D-473E-B19D-A9C5580A01CF

P356

Q40396297-60F594A1-7BDD-4805-B446-6942FD869415

P433

Q40396297-70DB4683-65DE-40FF-9DCF-877EC2C41B3F

P478

Q40396297-D4064E4C-37B7-48A7-874D-9758565E36FD

P577

Q40396297-D2D8A833-455E-4849-A264-DECE9662CCC5

P698

Q40396297-52FEA337-FC43-4987-B8E3-8017B73FD364

P356

10428199409049691

P1433

Leukemia & Lymphoma

P1476

RHAMM, a receptor for hyaluron ...... mediator in B cell malignancy?

@en

P2093

Belch AR

http://www.w3.org/2001/XMLSchema#string

Masellis-Smith A

http://www.w3.org/2001/XMLSchema#string

Pilarski LM

http://www.w3.org/2001/XMLSchema#string

Savani RC

http://www.w3.org/2001/XMLSchema#string

Turley EA

http://www.w3.org/2001/XMLSchema#string

Yang B

http://www.w3.org/2001/XMLSchema#string

P2860

Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor

Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells

ABC transporters: from microorganisms to man

Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein

Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein

Hyaluronan and its binding proteins, the hyaladherins

Hyaluronan and cell locomotion.

Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.

Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

P304

363-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428199409049691

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7529076

http://www.w3.org/2001/XMLSchema#string